Repaglinide: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Repaglinide. Educational only — not medical advice.
Labeled uses
Repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitation of Use: Repaglinide tablets should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
Source: FDA labeling via NIH DailyMed (set 7a93246c…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.